Health Condition 1: null- Type 2 diabetic patients
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 diabetic subjects Only with oral hypoglycemic agents [OHA] ie., metformin, Gliptins and / or sulphonylureas, HbA1c between 7.0 -11.0 % Willing to follow study protocol Willing to give informed consent
Exclusion criteria
Exclusion criteria: 1.Subjects with known allergy to cashew nuts 2.Subjects on statins 3.Subjects on insulin 4.LDL cholesterol > 190 mg/dl 5.Total serum cholesterol >240 mg/dl 6.Serum Triglycerides > 300 mg/dl 7.Any acute infections 8.Chronic diseases such as tuberculosis, disorders of liver, kidney, heart, lungs and other organs etc. 9.Pregnant and lactating Women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess changes in glycemic, and lipid profile among type 2 diabetic subjects by daily supplementation of cashew nuts in their dietsTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 2. To evaluate the effects of daily cashew nut supplementation on anthropometric measurements and clinical indicators of general healthTimepoint: 3 months | — |
Countries
India
Contacts
Madras Diabetes Research Foundation